The primary endpoint is to determine the number of days it takes to achieve a 50% reduction in blister count, and secondary endpoints include a reduction of baseline prednisone dose once the primary endpoint has been achieved. The trial will…
- Inicio
- Sobre nosotros
- Viviendo con P/P
- Investigación
- Involucrarse
- Noticias & Info
- Discussion Forums
